Patient Speed to Therapy: The Anchor to a Successful Hub Solution

Patient Speed to Therapy: The Anchor to a Successful Hub Solution
Patient Speed to Therapy: The Anchor to a Successful Hub Solution
Register Now

Date: Friday, April 29th
Time:1:00 PM EST / 10:00 AM PST

In this webcast TrialCard's Scott Dulitz explores the importance of speed to therapy as the anchor of a successful HUB program that delivers optimal patient outcomes. Scott examines how top HUB providers leverage technology and systems to quickly navigate the initial steps of a patient's treatment journey.


Speaker:  

Scott Dulitz, President of Market Access Solutions, Trialcard

Scott Dulitz, MBA, is Vice President of Market Access Solutions, where he is responsible for the product development and strategy of TrialCard's reimbursement HUB, nursing & adherence, and patient assistance service lines. Mr. Dulitz partners with an internal cross-functional team of IT, operations, client services, and marketing to develop best-in-class patient support programs for TrialCard's biopharmaceutical clients.

Before Mr. Dulitz joined TrialCard, he worked for Taiho Oncology as Director of Market Access Programs and Professional Relations. There, he led the strategic design and implementation of a limited specialty pharmacy network and patient support program for an oral oncology product. Prior to that role Mr. Dulitz held senior leadership positions in operations, product development, IT, and business development with UBC, an Express Scripts company, and AccessMED, a McKesson Specialty and US Oncology company. During his tenure at UBC and AccessMED Mr. Dulitz developed and managed several innovative, highly visible patient support programs for specialty drugs spanning a variety of therapeutic areas (oncology / hematology, rheumatology, gastroenterology, immunology, nephrology, neurology, pulmonology, endocrinology, transplant, radiopharmaceuticals, and mental health).

Mr. Dulitz has been an invited speaker at many national conferences on market access related topics. He has also authored several articles on distribution and patient support services for specialty drugs.

Mr. Dulitz received his Bachelor of Business Administration in Management Information Systems from Iowa State University and his Masters of Business Administration with an emphasis in finance from the University of Kansas.

Sponsored by:

Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.